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Figure S1: Affinities and kinetics of GILGFVFTL-HLA-A*0201 binding to the 
ALF3 and ALF8 TCRs. Surface plasmon resonance binding curves of the ALF3 and 
ALF8 TCRs in solid phase tested against the GILGFVFTL-HLA-A*0201-M1 complex 
in fluid phase across a range of concentrations (0.78–200 µM). The mean ± SEM of two 
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KD = 5.84 µM KD = 5.84 ± 0.1 µM KD = 7.71 ± 0.17 µM
 
Figure S2: Combinatorial peptide library screen of the 1E6 CD8+ T-cell clone in the 
absence of an intact pMHCI/CD8 interaction. 6 × 104 C1R-A*0201 D227K/T228A 
target cells were pulsed in duplicate with each mixture from a 10mer combinatorial 
peptide library (100 µM) for 2 hours at 37°C. 3 × 104 clonal 1E6 CD8+ T-cells were then 
added and the plates were incubated overnight at 37°C. Supernatants were assayed for 
MIP-1β by ELISA. The index peptide sequence is shown as red bars in each position.	
















































































































0.25 µg/ml DK25 
(pEC50 MIP-1β) 
0.5 µg/ml DK25 
(pEC50 MIP-1β) 
1 µg/ml DK25 
(pEC50 MIP-1β) 
1E6  6.74921 - - - 
3F2  6.02653 - - - 
4C6  6.34537 - - - 
ALF3  8.27954 7.9456 7.64974 7.76992 
SB27  8.82749 8.81323 8.55271 8.72455 
MCNLV  9.40681 8.82467 8.7935 8.60756 
 







0.25 µg/ml DK25 
(pEC50 lysis) 
0.5 µg/ml DK25 
(pEC50 lysis) 
1 µg/ml DK25 
(pEC50 lysis) 
1E6  7.34425 - - - 
3F2  7.06595 - - - 
4C6  7.58755 - - - 
ALF3  9.41053 8.69299 8.55927 8.62777 
SB27  9.22728 9.06544 8.90326 8.44131 
MCNLV  9.29825 9.11505 8.51186 8.24729 
 





0.25 µg/ml DK25 
(delta pEC50 MIP-1β) 
0.5 µg/ml DK25 
(delta pEC50 MIP-1β) 
1 µg/ml DK25 
(delta pEC50 MIP-1β) 
1E6  >1.75 >1.75 >1.75 
3F2  >1.03 >1.03 >1.03 
4C6  >1.35 >1.35 >1.35 
ALF3  0.33394 0.6298 0.50962 
SB27  0.01426 0.27478 0.10299 
MCNLV  0.58214 0.61331 0.79925 
 
Table S1C: DK25-induced shifts in functional sensitivity, measured by MIP-1β production, 




0.25 µg/ml DK25 
(delta pEC50 lysis) 
0.5 µg/ml DK25 
(delta pEC50 lysis) 
1 µg/ml DK25 
(delta pEC50 lysis) 
1E6  >2.34 >2.34 >2.34 
3F2  >2.07 >2.07 >2.07 
4C6  >2.59 >2.59 >2.59 
ALF3  0.71754 0.85126 0.78276 
SB27  0.16184 0.32402 0.78597 
MCNLV  0.78639 0.78639 1.05096 
 
Table S1D: DK25-induced shifts in functional sensitivity, measured by killing activity, 
expressed as delta pEC50 (Figure 6). 
 
1. Sprent P, Smeeton NC. Applied nonparametric statistical methods. Chapman & 
Hall/CRC, London (2007). 
 
